Immune modulatory vaccines targeting tumor microenvironment antigens: recent advances in oncology and beyond

肿瘤微环境 免疫系统 间质细胞 癌症研究 抗原 免疫学 医学 免疫疗法 免疫耐受 免疫检查点 细胞毒性T细胞 癌症 生物 细胞因子 黑色素瘤 癌症免疫疗法 髓样 促炎细胞因子 T细胞 抗原呈递 抗原提呈细胞 基质 免疫抑制 获得性免疫系统 癌细胞 骨髓
作者
Mads Hald Andersen
出处
期刊:Signal Transduction and Targeted Therapy [Springer Nature]
卷期号:11 (1) 被引量:20
标识
DOI:10.1038/s41392-026-02710-8
摘要

Immune modulatory vaccines (IMVs) are an emerging class of immunotherapies designed to expand anti-regulatory T cells (anti-Tregs) that selectively target immunosuppressive elements within the tumor microenvironment (TME). Unlike conventional cancer vaccines aimed at tumor-associated antigens on malignant cells, IMVs target tumor microenvironment antigens (TMAs), such as indoleamine 2,3-dioxygenase (IDO), PD-L1, arginase-1 (ARG1), and transforming growth factor-β (TGF-β), which are expressed by malignant, myeloid, regulatory, endothelial, and stromal populations. IMVs elicit both CD8⁺ and CD4⁺ T-cell responses: CD8⁺ T cells can mediate cytotoxic elimination of TMA-expressing suppressive cells, whereas CD4⁺ T cells can induce proinflammatory cytokine programs that reprogram myeloid and stromal compartments toward immune-permissive states. Through these combined cytolytic and modulatory mechanisms, IMVs remodel suppressive cellular networks, improve antigen presentation, enhance immune infiltration, and amplify endogenous tumor-specific immunity. Early-phase clinical studies targeting IDO and PD-L1 have shown robust immunogenicity, favorable tolerability, and encouraging activity across multiple solid tumors, particularly in combination with immune checkpoint blockade. A phase III study in first-line advanced melanoma recently demonstrated that a therapeutic vaccine, when combined with anti-PD-1 therapy, can improve progression-free survival in patients with metastatic disease. The strongest signal was observed in PD-1-naïve disease and in PD-L1-negative tumors. Next-generation IMVs directed against ARG1 and TGF-β aim to address immune exclusion and desmoplastic stroma and are being developed across peptide- and mRNA-based platforms with favorable safety profiles that support evaluation in earlier-stage settings. Beyond oncology, analogous microenvironment antigens are induced in chronic and acute infections, suggesting that IMV principles may generalize to settings where regulatory circuits constrain pathogen clearance.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
施不评发布了新的文献求助10
刚刚
FashionBoy的应助被靓丽的若南采纳,获得10
刚刚
欢喜的半鬼完成签到 ,获得积分10
刚刚
天天快乐的应助被MiYou采纳,获得10
1秒前
GamAooL发布了新的文献求助30
1秒前
星星之火完成签到,获得积分10
2秒前
bcsunny2022完成签到,获得积分10
3秒前
乐乐发布了新的文献求助10
3秒前
3秒前
4秒前
汉堡包的应助被yzm采纳,获得10
4秒前
能干的正豪完成签到,获得积分10
4秒前
小南瓜发布了新的文献求助10
4秒前
111完成签到 ,获得积分10
4秒前
李爱国的应助被孤独的唯雪采纳,获得10
4秒前
所所的应助被Tong123采纳,获得10
4秒前
5秒前
xiaozhang完成签到,获得积分20
5秒前
369ninja的应助被Pomelotea采纳,获得10
5秒前
7秒前
7秒前
深情安青的应助被chenrao采纳,获得10
8秒前
慕青的应助被寒酥采纳,获得10
8秒前
8秒前
鲤鱼雁风完成签到,获得积分10
8秒前
9秒前
wanci的应助被白色采纳,获得10
9秒前
9秒前
星辰大海的应助被雨雨青青采纳,获得10
9秒前
Elenaiga完成签到 ,获得积分10
9秒前
zhzha发布了新的文献求助10
9秒前
寒冷黎云发布了新的文献求助10
10秒前
ZM9450完成签到,获得积分10
10秒前
10秒前
终梦的应助被wyn采纳,获得10
10秒前
11秒前
11秒前
嘴遁老铁叽完成签到,获得积分10
11秒前
单薄的寄灵完成签到 ,获得积分20
11秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175556
求助须知:如何正确求助?哪些是违规求助? 9567240
关于积分的说明 21791502
捐赠科研通 7770174
什么是DOI,文献DOI怎么找? 3431868
关于科研通互助平台的介绍 2556244
邀请新用户注册赠送积分活动 2477299